Share-based Payment Arrangement, Expense of BIORA THERAPEUTICS, INC. from 30 Jun 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BIORA THERAPEUTICS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2019 to 30 Sep 2024.
  • BIORA THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $1,281,000, a 88% decline year-over-year.
  • BIORA THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was $5,939,000, a 65% decline year-over-year.
  • BIORA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $16,475,000, a 111% increase from 2022.
  • BIORA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2022 was $7,804,000, a 42% decline from 2021.
  • BIORA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2021 was $13,556,000, a 27% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BIORA THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $5,939,000 $1,281,000 -$9,250,000 -88% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $15,189,000 $1,573,000 -$441,000 -22% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $15,630,000 $1,539,000 -$845,000 -35% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $16,475,000 $1,546,000 -$375,000 -20% 01 Oct 2023 31 Dec 2023 10-K 01 Apr 2024 2023 FY
Q3 2023 $16,850,000 $10,531,000 +$8,147,000 +342% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $8,703,000 $2,014,000 +$568,000 +39% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $8,135,000 $2,384,000 +$331,000 +16% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $7,804,000 $1,921,000 -$663,000 -26% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $8,467,000 $2,384,000 -$1,488,000 -38% 01 Jul 2022 30 Sep 2022 10-Q 15 May 2024 2024 Q1
Q2 2022 $9,955,000 $1,446,000 -$3,024,000 -68% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $12,979,000 $2,053,000 -$577,000 -22% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $13,556,000 $2,584,000 +$371,000 +17% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $13,185,000 $3,872,000 +$498,000 +15% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $12,687,000 $4,470,000 +$1,446,000 +48% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $11,241,000 $2,630,000 +$573,000 +28% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $10,668,000 $2,213,000 +$1,313,000 +146% 01 Oct 2020 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 $9,355,000 $3,374,000 +$2,743,000 +435% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $6,612,000 $3,024,000 +$2,427,000 +407% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $4,185,000 $2,057,000 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $900,000 01 Jan 2020 31 Jan 2020 10-K 28 Mar 2022 2021 FY
Q3 2019 $631,000 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $597,000 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2

BIORA THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $16,475,000 +$8,671,000 +111% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2024 2023 FY
2022 $7,804,000 -$5,752,000 -42% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $13,556,000 +$2,888,000 +27% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $10,668,000 +$8,293,000 +349% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022 2021 FY
2019 $2,375,000 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.